Literature DB >> 2228341

Lack of interaction between famotidine and warfarin.

I De Lepeleire1, A Van Hecken, R Verbesselt, T B Tjandra-Maga, A Buntinx, L Distlerath, P J De Schepper.   

Abstract

In eight healthy male volunteers taking daily subtherapeutic doses of warfarin (mean daily dose = 4.0 mg), the addition of famotidine 40 mg once-a-day for seven days did not alter the prothrombin time profile, thrombotest coagulation time or total warfarin steady-state plasma concentration. Plasma peak concentration, time to peak concentration and area under curve for famotidine were not affected by the co-administration of warfarin. However the plasma half-life of famotidine was slightly, but statistically significantly longer (p less than 0.05) during maintenance treatment with warfarin (mean +/- s.e.m.: 2.58 +/- 0.14 h versus 2.96 +/- 0.16 h respectively).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2228341

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Res        ISSN: 0251-1649


  2 in total

1.  Does smoking influence the pharmacokinetics and pharmacodynamics of the H2-receptor antagonist famotidine?

Authors:  L C Baak; S Ganesh; J B Jansen; C B Lamers
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

Review 2.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.